Dr. Michael Kyle joined Currax Pharmaceuticals LLC in 2022 where he serves as SVP, Chief Medical Officer. As a member of the Currax Senior Leadership Team, Michael leads and manages all aspects of clinical development, clinical operations, medical affairs, safety and pharmacovigilance, and regulatory affairs.

Prior to joining Currax Pharmaceuticals, Michael served as Head of Development at China’s largest pharmaceutical company, Jiangsu Hengrui Pharmaceuticals, where he led and managed all aspects of clinical development, medical, and regulatory affairs. Previously, Michael served in clinical development and medical affairs roles at Pfizer, including as Chief Medical Officer of Consumer Health, and as VP, Head of Global Clinical Sciences and Operations for the Upjohn division.

Michael brings a diverse set of skills, having served as Medical Director at Radiant Research, where he led the clinical trial center, successfully conducting nearly 250 (Phase I-IV) clinical trials across 15+ therapeutic areas including vaccines, diagnostics, and devices. Additionally, he served as a practicing family physician in private practice for 12 years, as the Medical Director at Assurant Health, and at Loyola Medical School, as an Independent Faculty Teaching Attending.

Michael earned his Bachelor of Science in Psychology from Loyola University and his Medical Degree from Rush Medical College in Chicago. He is a board-certified family physician and completed his residency training at West Suburban Family Medicine Residency Program in Oak Park/River Forest, IL.